Ownership Summary
Cartesian Therapeutics, Inc. (NASDAQ:RNAC) has 2 institutional investors with active 13F positions as of March 2026.
- Collectively, these holders controlled 0.7% of Cartesian Therapeutics's outstanding shares in March 2026, down from 0.7% in December 2025.
- They maintained total shares held in Cartesian Therapeutics by 0.0% from last quarter, and the number of investors in RNAC decreased 33.33% annually.
- Of these 2 holders, 0 added to their stakes in Cartesian Therapeutics, 0 trimmed positions, and 2 made no changes.
- The aggregate institutional position in Cartesian Therapeutics amounted to 178.36K shares as of March 2026, with no net change quarter on quarter, and down 2.53Mn shares year over year.
- IRONWOOD INVESTMENT MANAGEMENT LLC leads ownership in RNAC with 170.09K shares as of March 31, 2026, equal to 0.63% of outstanding shares.
- According to Business Quant data, leading holders of RNAC for March 2026 are IRONWOOD INVESTMENT MANAGEMENT LLC (170.09K), Sterling Capital Management LLC (8.27K).